Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5ht2 agonists for controlling IOP and treating glaucoma

5ht2 agonists for controlling IOP and treating glaucoma

US Patent 6927233 · Granted Aug 9, 2005

Estimated economic value: $117,643,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating gl2010
Substituted furo[2,3-g]indazoles for the treatment of glaucoma2009
Substituted furo[2,3-g]indazoles for the treatment of glaucoma2009
Substituted 1-alkylamino-1-H-indazoles for the treatment of glaucoma2008
Substituted 1-alkylamino-1-H-indazoles for the treatment of glaucoma2008
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma2008
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma2008
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma2008
Use of MDCK cell line to predict corneal penetration of drugs2007
Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders2007
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma2007
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma2007